Cite
HARVARD Citation
Rasenack, M. et al. (2016). Disease activity return after natalizumab cessation in multiple sclerosis. Expert review of neurotherapeutics. pp. 587-594. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rasenack, M. et al. (2016). Disease activity return after natalizumab cessation in multiple sclerosis. Expert review of neurotherapeutics. pp. 587-594. [Online].